
EU pharmaceutical regulation reforms needed to drive innovation and investment, experts suggest
New research from Bayes Business School, in collaboration with biopharmaceuticals company Merck KGaA, suggests member states from the European Union (EU) must work more closely together, provide better incentives for the development of new medicines […]